{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:26:21Z","timestamp":1793154381516,"version":"4.5.0"},"reference-count":29,"publisher":"SAGE Publications","issue":"13","license":[{"start":{"date-parts":[[2016,7,10]],"date-time":"2016-07-10T00:00:00Z","timestamp":1468108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Int J STD AIDS"],"published-print":{"date-parts":[[2016,11]]},"abstract":"<jats:p>There is a lack of research on health care providers\u2019 use of and perspectives on expedited partner therapy in a state where expedited partner therapy is not prohibited or explicitly allowed. The aim of our study was to understand if and how health care providers use expedited partner therapy, if specific demographic factors and knowledge contribute to increased use of expedited partner therapy, and to describe barriers and facilitators to the use of expedited partner therapy in Pittsburgh, Pennsylvania. A convenience sample of 112 health care providers from diverse disciplines who treat young women at risk for chlamydia completed an online survey. About 11% of health care providers used expedited partner therapy consistently. Those who self-reported that they were knowledgeable about expedited partner therapy were more likely to use expedited partner therapy (73% vs. 49%, p\u2009=\u2009.009) as were those who said no or were unsure about their institution\u2019s guidelines for expedited partner therapy (35% vs. 22%, p\u2009=\u20090.01) (62% vs. 57%, p\u2009=\u20090.01). The most commonly reported facilitator of expedited partner therapy was having clear legal guidelines (86%). This study finds that in a setting where expedited partner therapy is not expressly permitted, health care providers still use the practice but also experience barriers that limit uptake. Legislation expressly endorsing expedited partner therapy in the state and in medical institutions is needed to increase expedited partner therapy use.<\/jats:p>","DOI":"10.1177\/0956462415610689","type":"journal-article","created":{"date-parts":[[2015,10,7]],"date-time":"2015-10-07T21:24:12Z","timestamp":1444253052000},"page":"1180-1186","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":14,"title":["Perspectives on expedited partner therapy for chlamydia: a survey of health care providers"],"prefix":"10.1177","volume":"27","author":[{"given":"EA","family":"Rosenfeld","sequence":"first","affiliation":[{"name":"VA Women\u2019s Health, VA Pittsburgh Healthcare System, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Marx","sequence":"additional","affiliation":[{"name":"Department of Behavioral and Community Health Sciences, Graduate School of Public Health; University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MA","family":"Terry","sequence":"additional","affiliation":[{"name":"Department of Behavioral and Community Health Sciences, Graduate School of Public Health; University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Stall","sequence":"additional","affiliation":[{"name":"Department of Behavioral and Community Health Sciences, Graduate School of Public Health; University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Flatt","sequence":"additional","affiliation":[{"name":"Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Borrero","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA, USA"},{"name":"Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Miller","sequence":"additional","affiliation":[{"name":"Division of Adolescent Medicine, Children\u2019s Hospital of Pittsburgh of UPMC, University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2016,7,10]]},"reference":[{"key":"bibr1-0956462415610689","unstructured":"Centers for Disease Control Prevention.\n                      Sexually transmitted disease surveillance 2013\n                      . Atlanta: US Department of Health and Human Services, 2014"},{"key":"bibr2-0956462415610689","unstructured":"Centers for Disease Control and Prevention.\n                      Expedited partner therapy in the management of sexually transmitted diseases\n                      . Atlanta, GA: US Department of Health and Human Services, 2006"},{"key":"bibr3-0956462415610689","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041681"},{"key":"bibr4-0956462415610689","doi-asserted-by":"publisher","DOI":"10.1097\/00007435-200301000-00011"},{"key":"bibr5-0956462415610689","doi-asserted-by":"publisher","DOI":"10.1086\/432476"},{"key":"bibr6-0956462415610689","unstructured":"Centers for Disease Control and Prevention.\n                      Guidance on the Use of Expedited Partner Therapy in the Treatment of Gonorrhea\n                      . http:\/\/www.cdc.gov\/std\/ept\/GC-EPT-GuidanceNov-2012.pdf (2012, accessed 25 November 2014)"},{"key":"bibr7-0956462415610689","unstructured":"Centers for Disease Control and Prevention.\n                      Legal Status of Expedited Partner Therapy\n                      . http:\/\/www.cdc.gov\/STD\/ept\/legal\/default.htm (accessed 1 June 2015)"},{"key":"bibr8-0956462415610689","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e3182853c61"},{"key":"bibr9-0956462415610689","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2013.10.196"},{"key":"bibr10-0956462415610689","doi-asserted-by":"publisher","DOI":"10.1097\/01.olq.0000219865.65253.29"},{"key":"bibr11-0956462415610689","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2010.047670"},{"key":"bibr12-0956462415610689","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-010-0159-3"},{"key":"bibr13-0956462415610689","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e318237b723"},{"key":"bibr14-0956462415610689","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2011-3764"},{"key":"bibr15-0956462415610689","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e3181d012e0"},{"key":"bibr16-0956462415610689","unstructured":"Centers for Disease Control Prevention.\n                      Sexually transmitted diseases treatment guidelines, 2010\n                      . Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention, 2010"},{"key":"bibr17-0956462415610689","doi-asserted-by":"crossref","unstructured":"Rosenfeld EA, Marx J, Terry MA, et\u00a0al. Healthcare providers\u2019 perspectives on expedited partner therapy for chlamydia: a qualitative study.\n                      Sex Transm Infect\n                      2015; 91: 407\u2013411","DOI":"10.1136\/sextrans-2014-051873"},{"key":"bibr18-0956462415610689","unstructured":"Boyatzis RE.\n                      Transforming qualitative information: thematic analysis and code development\n                      . Thousand Oaks, CA: SAGE, 1998"},{"key":"bibr19-0956462415610689","doi-asserted-by":"publisher","DOI":"10.1097\/01.olq.0000151417.43230.18"},{"key":"bibr20-0956462415610689","doi-asserted-by":"publisher","DOI":"10.1258\/ijsa.2011.010425"},{"key":"bibr21-0956462415610689","doi-asserted-by":"publisher","DOI":"10.1542\/peds.114.2.e220"},{"key":"bibr22-0956462415610689","volume-title":"National intimate partner and sexual violence survey","author":"Black MC","year":"2011"},{"key":"bibr23-0956462415610689","doi-asserted-by":"publisher","DOI":"10.1363\/4306011"},{"key":"bibr24-0956462415610689","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2007.0757"},{"key":"bibr25-0956462415610689","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2007.0665"},{"key":"bibr26-0956462415610689","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e318249ff74"},{"key":"bibr27-0956462415610689","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000426427.79586.3b"},{"key":"bibr28-0956462415610689","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2010.047258"},{"key":"bibr29-0956462415610689","doi-asserted-by":"publisher","DOI":"10.1071\/SH10031"}],"container-title":["International Journal of STD &amp; AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0956462415610689","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0956462415610689","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0956462415610689","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:35:36Z","timestamp":1777674936000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0956462415610689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,10]]},"references-count":29,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["10.1177\/0956462415610689"],"URL":"https:\/\/doi.org\/10.1177\/0956462415610689","relation":{},"ISSN":["0956-4624","1758-1052"],"issn-type":[{"value":"0956-4624","type":"print"},{"value":"1758-1052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,10]]}}}